Sonoma Biotherapeutics is a South San Francisco and Seattle-based company leading the development of adoptive T-reg therapies cell for autoimmune and degenerative diseases. Using next generation genome editing and target-specific cell therapy, Sonoma is focused on developing its best-in-class platform across the entire spectrum of T-reg cell therapeutic capabilities. Founded by pioneers in Treg biology and cell therapy, the company brings together leadingexpertiseand proprietary methodologies for the discovery and development of diseasemodifyingand curative therapies. More information at [www.sonomabio.com](http://www.sonomabio.com/).
We seek an experienced Regulatory professional to manage regulatory activities associated with pipeline and late phase clinical development, working in partnership with the development R&D team and CMOs. This position reports into the SVP Regulatory Affairs and Quality Assurance. The candidate must be able to interpret biologic/ATMP regulations as they apply to given phases of drug development including preclinical, clinical and commercial. This is an exciting team-building, hands-on leadership role within the Sonoma Biotherapeutics team. The position will be based in the US in the SSF headquarters. Remote US candidates are also considered.
Apply for This Job
Sonoma Biotherapeutics is a South San Francisco and Seattle-based clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases by restoring balance to the immune system. Founded by pioneers in Treg biology and cell therapy, the company brings together leading expertise and proprietary methodologies for the discovery and development of disease modifying and curative therapies. Sonoma Bio has initiated two Phase 1 studies to evaluate the safety and proof-of-mechanism of the company’s lead Treg cell therapy candidate, SBT-77-7101, in patients with rheumatoid arthritis and hidradenitis suppurativa. The company has a partnership with Regeneron to discover, develop and commercialize novel regulatory T cell therapies. More information at www.sonomabio.com.
View company profile →